APO Research
Talk to an analyst

APO RESEARCH · REPORT

Natural and Bio-Based Antimicrobials

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Natural and Bio-Based Antimicrobials Market Outlook and Growth Opportunities 2026

1 February 2026198 pages

Choose your research edition.

Industry ResearchNatural and Bio-Based Antimicrobials Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Natural and Bio-Based Antimicrobials Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Natural and Bio-Based Antimicrobials Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Natural and Bio-Based Antimicrobials Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Natural and Bio-Based Antimicrobials Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Natural and Bio-Based Antimicrobials market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Natural and Bio-Based Antimicrobials is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Natural and Bio-Based Antimicrobials is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Natural and Bio-Based Antimicrobials is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Natural and Bio-Based Antimicrobials market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Natural and Bio-Based Antimicrobials market include Active Micro Technologies, Akema Fine Chemicals, Ashland, Chemipol, DuPont Nutrition & Biosciences, Evident Ingredients, Evonik, Minasolve and Sabinsa, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Natural and Bio-Based Antimicrobials market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Natural and Bio-Based Antimicrobials and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Natural and Bio-Based Antimicrobials sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Natural and Bio-Based Antimicrobials market size, projected growth trends, production technologies, key applications, and end-use industries.

Natural and Bio-Based Antimicrobials Segment by Company

Active Micro Technologies

Akema Fine Chemicals

Ashland

Chemipol

DuPont Nutrition & Biosciences

Evident Ingredients

Evonik

Minasolve

Sabinsa

SEPPIC

Troy Corporation

Vedeqsa

Natural and Bio-Based Antimicrobials Segment by Type

Plant Extracts

Plant Derivatives

Others

Natural and Bio-Based Antimicrobials Segment by Application

Cosmetic

Food

Medicine

Others

Natural and Bio-Based Antimicrobials Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Natural and Bio-Based Antimicrobials status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Natural and Bio-Based Antimicrobials market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Natural and Bio-Based Antimicrobials significant trends, drivers, influence factors in global and regions.

6. To analyze Natural and Bio-Based Antimicrobials competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Natural and Bio-Based Antimicrobials market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Natural and Bio-Based Antimicrobials and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Natural and Bio-Based Antimicrobials.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Natural and Bio-Based Antimicrobials market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Natural and Bio-Based Antimicrobials industry.

Chapter 3: Detailed analysis of Natural and Bio-Based Antimicrobials manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Natural and Bio-Based Antimicrobials in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Natural and Bio-Based Antimicrobials in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Natural and Bio-Based Antimicrobials Industry Trends Table 2. Natural and Bio-Based Antimicrobials Industry Drivers Table 3. Natural and Bio-Based Antimicrobials Industry Opportunities and Challenges Table 4. Natural and Bio-Based Antimicrobials Industry Restraints Table 5. Global Natural and Bio-Based Antimicrobials Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Natural and Bio-Based Antimicrobials Revenue Share by Company (2021-2026) Table 7. Global Natural and Bio-Based Antimicrobials Sales Volume by Company (t) & (2021-2026) Table 8. Global Natural and Bio-Based Antimicrobials Sales Volume Share by Company (2021-2026) Table 9. Global Natural and Bio-Based Antimicrobials Average Price (USD/t) of Company (2021-2026) Table 10. Global Natural and Bio-Based Antimicrobials Company Ranking, (2024-2026) & (USD Million) Table 11. Global Natural and Bio-Based Antimicrobials Key Company Manufacturing Base & Headquarters Table 12. Global Natural and Bio-Based Antimicrobials Company, Product Type & Application Table 13. Global Natural and Bio-Based Antimicrobials Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Natural and Bio-Based Antimicrobials by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Plant Extracts Table 18. Significant Companies of Plant Derivatives Table 19. Significant Companies of Others Table 20. Global Natural and Bio-Based Antimicrobials Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 21. Global Natural and Bio-Based Antimicrobials Sales Volume by Type (2021-2026) & (t) Table 22. Global Natural and Bio-Based Antimicrobials Sales Volume by Type (2027-2032) & (t) Table 23. Global Natural and Bio-Based Antimicrobials Sales Volume Share by Type (2021-2026) Table 24. Global Natural and Bio-Based Antimicrobials Sales Volume Share by Type (2027-2032) Table 25. Global Natural and Bio-Based Antimicrobials Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Natural and Bio-Based Antimicrobials Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Natural and Bio-Based Antimicrobials Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Natural and Bio-Based Antimicrobials Sales Value Share by Type (2021-2026) Table 29. Global Natural and Bio-Based Antimicrobials Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Cosmetic Table 31. Significant Companies of Food Table 32. Significant Companies of Medicine Table 33. Significant Companies of Others Table 34. Global Natural and Bio-Based Antimicrobials Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 35. Global Natural and Bio-Based Antimicrobials Sales Volume by Application (2021-2026) & (t) Table 36. Global Natural and Bio-Based Antimicrobials Sales Volume by Application (2027-2032) & (t) Table 37. Global Natural and Bio-Based Antimicrobials Sales Volume Share by Application (2021-2026) Table 38. Global Natural and Bio-Based Antimicrobials Sales Volume Share by Application (2027-2032) Table 39. Global Natural and Bio-Based Antimicrobials Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Natural and Bio-Based Antimicrobials Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Natural and Bio-Based Antimicrobials Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Natural and Bio-Based Antimicrobials Sales Value Share by Application (2021-2026) Table 43. Global Natural and Bio-Based Antimicrobials Sales Value Share by Application (2027-2032) Table 44. Global Natural and Bio-Based Antimicrobials Sales by Region: 2021 VS 2025 VS 2032 (t) Table 45. Global Natural and Bio-Based Antimicrobials Sales by Region (2021-2026) & (t) Table 46. Global Natural and Bio-Based Antimicrobials Sales Market Share by Region (2021-2026) Table 47. Global Natural and Bio-Based Antimicrobials Sales by Region (2027-2032) & (t) Table 48. Global Natural and Bio-Based Antimicrobials Sales Market Share by Region (2027-2032) Table 49. Global Natural and Bio-Based Antimicrobials Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Natural and Bio-Based Antimicrobials Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Natural and Bio-Based Antimicrobials Sales Value Share by Region (2021-2026) Table 52. Global Natural and Bio-Based Antimicrobials Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Natural and Bio-Based Antimicrobials Sales Value Share by Region (2027-2032) Table 54. Global Natural and Bio-Based Antimicrobials Market Average Price (USD/t) by Region (2021-2026) Table 55. Global Natural and Bio-Based Antimicrobials Market Average Price (USD/t) by Region (2027-2032) Table 56. Global Natural and Bio-Based Antimicrobials Sales by Country: 2021 VS 2025 VS 2032 (t) Table 57. Global Natural and Bio-Based Antimicrobials Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Natural and Bio-Based Antimicrobials Sales by Country (2021-2026) & (t) Table 59. Global Natural and Bio-Based Antimicrobials Sales Market Share by Country (2021-2026) Table 60. Global Natural and Bio-Based Antimicrobials Sales by Country (2027-2032) & (t) Table 61. Global Natural and Bio-Based Antimicrobials Sales Market Share by Country (2027-2032) Table 62. Global Natural and Bio-Based Antimicrobials Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Natural and Bio-Based Antimicrobials Sales Value Market Share by Country (2021-2026) Table 64. Global Natural and Bio-Based Antimicrobials Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Natural and Bio-Based Antimicrobials Sales Value Market Share by Country (2027-2032) Table 66. Active Micro Technologies Company Information Table 67. Active Micro Technologies Business Overview Table 68. Active Micro Technologies Natural and Bio-Based Antimicrobials Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 69. Active Micro Technologies Natural and Bio-Based Antimicrobials Product Portfolio Table 70. Active Micro Technologies Recent Development Table 71. Akema Fine Chemicals Company Information Table 72. Akema Fine Chemicals Business Overview Table 73. Akema Fine Chemicals Natural and Bio-Based Antimicrobials Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 74. Akema Fine Chemicals Natural and Bio-Based Antimicrobials Product Portfolio Table 75. Akema Fine Chemicals Recent Development Table 76. Ashland Company Information Table 77. Ashland Business Overview Table 78. Ashland Natural and Bio-Based Antimicrobials Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 79. Ashland Natural and Bio-Based Antimicrobials Product Portfolio Table 80. Ashland Recent Development Table 81. Chemipol Company Information Table 82. Chemipol Business Overview Table 83. Chemipol Natural and Bio-Based Antimicrobials Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 84. Chemipol Natural and Bio-Based Antimicrobials Product Portfolio Table 85. Chemipol Recent Development Table 86. DuPont Nutrition & Biosciences Company Information Table 87. DuPont Nutrition & Biosciences Business Overview Table 88. DuPont Nutrition & Biosciences Natural and Bio-Based Antimicrobials Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 89. DuPont Nutrition & Biosciences Natural and Bio-Based Antimicrobials Product Portfolio Table 90. DuPont Nutrition & Biosciences Recent Development Table 91. Evident Ingredients Company Information Table 92. Evident Ingredients Business Overview Table 93. Evident Ingredients Natural and Bio-Based Antimicrobials Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 94. Evident Ingredients Natural and Bio-Based Antimicrobials Product Portfolio Table 95. Evident Ingredients Recent Development Table 96. Evonik Company Information Table 97. Evonik Business Overview Table 98. Evonik Natural and Bio-Based Antimicrobials Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 99. Evonik Natural and Bio-Based Antimicrobials Product Portfolio Table 100. Evonik Recent Development Table 101. Minasolve Company Information Table 102. Minasolve Business Overview Table 103. Minasolve Natural and Bio-Based Antimicrobials Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 104. Minasolve Natural and Bio-Based Antimicrobials Product Portfolio Table 105. Minasolve Recent Development Table 106. Sabinsa Company Information Table 107. Sabinsa Business Overview Table 108. Sabinsa Natural and Bio-Based Antimicrobials Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 109. Sabinsa Natural and Bio-Based Antimicrobials Product Portfolio Table 110. Sabinsa Recent Development Table 111. SEPPIC Company Information Table 112. SEPPIC Business Overview Table 113. SEPPIC Natural and Bio-Based Antimicrobials Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 114. SEPPIC Natural and Bio-Based Antimicrobials Product Portfolio Table 115. SEPPIC Recent Development Table 116. Troy Corporation Company Information Table 117. Troy Corporation Business Overview Table 118. Troy Corporation Natural and Bio-Based Antimicrobials Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 119. Troy Corporation Natural and Bio-Based Antimicrobials Product Portfolio Table 120. Troy Corporation Recent Development Table 121. Vedeqsa Company Information Table 122. Vedeqsa Business Overview Table 123. Vedeqsa Natural and Bio-Based Antimicrobials Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 124. Vedeqsa Natural and Bio-Based Antimicrobials Product Portfolio Table 125. Vedeqsa Recent Development Table 126. Key Raw Materials Table 127. Raw Materials Key Suppliers Table 128. Natural and Bio-Based Antimicrobials Distributors List Table 129. Natural and Bio-Based Antimicrobials Customers List Table 130. Research Programs/Design for This Report Table 131. Authors List of This Report Table 132. Secondary Sources Table 133. Primary Sources List of Figures Figure 1. Natural and Bio-Based Antimicrobials Product Image Figure 2. Global Natural and Bio-Based Antimicrobials Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Natural and Bio-Based Antimicrobials Sales Value (2021-2032) & (US$ Million) Figure 4. Global Natural and Bio-Based Antimicrobials Sales (2021-2032) & (t) Figure 5. Global Natural and Bio-Based Antimicrobials Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Natural and Bio-Based Antimicrobials Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Plant Extracts Image Figure 10. Plant Derivatives Image Figure 11. Others Image Figure 12. Global Natural and Bio-Based Antimicrobials Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 13. Global Natural and Bio-Based Antimicrobials Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Natural and Bio-Based Antimicrobials Sales Volume Share by Type (2021-2032) Figure 15. Global Natural and Bio-Based Antimicrobials Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Natural and Bio-Based Antimicrobials Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Natural and Bio-Based Antimicrobials Sales Value Share by Type (2021-2032) Figure 18. Cosmetic Image Figure 19. Food Image Figure 20. Medicine Image Figure 21. Others Image Figure 22. Global Natural and Bio-Based Antimicrobials Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 23. Global Natural and Bio-Based Antimicrobials Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Natural and Bio-Based Antimicrobials Sales Volume Share by Application (2021-2032) Figure 25. Global Natural and Bio-Based Antimicrobials Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Natural and Bio-Based Antimicrobials Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Natural and Bio-Based Antimicrobials Sales Value Share by Application (2021-2032) Figure 28. Global Natural and Bio-Based Antimicrobials Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 29. Global Natural and Bio-Based Antimicrobials Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Natural and Bio-Based Antimicrobials Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Natural and Bio-Based Antimicrobials Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Natural and Bio-Based Antimicrobials Sales Value (2021-2032) & (US$ Million) Figure 33. North America Natural and Bio-Based Antimicrobials Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Natural and Bio-Based Antimicrobials Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Natural and Bio-Based Antimicrobials Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Natural and Bio-Based Antimicrobials Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Natural and Bio-Based Antimicrobials Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Natural and Bio-Based Antimicrobials Sales Value (2021-2032) & (US$ Million) Figure 39. South America Natural and Bio-Based Antimicrobials Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Natural and Bio-Based Antimicrobials Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Natural and Bio-Based Antimicrobials Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Natural and Bio-Based Antimicrobials Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Natural and Bio-Based Antimicrobials Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Plant Extracts
  • Plant Derivatives
  • Others
Applications
  • Cosmetic
  • Food
  • Medicine
  • Others
Companies covered
  • Active Micro Technologies
  • Akema Fine Chemicals
  • Ashland
  • Chemipol
  • DuPont Nutrition & Biosciences
  • Evident Ingredients
  • Evonik
  • Minasolve
  • Sabinsa
  • SEPPIC
  • Troy Corporation
  • Vedeqsa

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Natural and Bio-Based Antimicrobials Sales Value (2021-2032)
  4. 1.2.2 Global Natural and Bio-Based Antimicrobials Sales Volume (2021-2032)
  5. 1.2.3 Global Natural and Bio-Based Antimicrobials Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Natural and Bio-Based Antimicrobials Market Dynamics
  1. 2.1 Natural and Bio-Based Antimicrobials Industry Trends
  2. 2.2 Natural and Bio-Based Antimicrobials Industry Drivers
  3. 2.3 Natural and Bio-Based Antimicrobials Industry Opportunities and Challenges
  4. 2.4 Natural and Bio-Based Antimicrobials Industry Restraints
3 Natural and Bio-Based Antimicrobials Market by Company
  1. 3.1 Global Natural and Bio-Based Antimicrobials Company Revenue Ranking in 2025
  2. 3.2 Global Natural and Bio-Based Antimicrobials Revenue by Company (2021-2026)
  3. 3.3 Global Natural and Bio-Based Antimicrobials Sales Volume by Company (2021-2026)
  4. 3.4 Global Natural and Bio-Based Antimicrobials Average Price by Company (2021-2026)
  5. 3.5 Global Natural and Bio-Based Antimicrobials Company Ranking (2024-2026)
  6. 3.6 Global Natural and Bio-Based Antimicrobials Company Manufacturing Base and Headquarters
  7. 3.7 Global Natural and Bio-Based Antimicrobials Company Product Type and Application
  8. 3.8 Global Natural and Bio-Based Antimicrobials Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Natural and Bio-Based Antimicrobials Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Natural and Bio-Based Antimicrobials Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Natural and Bio-Based Antimicrobials Market by Type
  1. 4.1 Natural and Bio-Based Antimicrobials Type Introduction
  2. 4.1.1 Plant Extracts
  3. 4.1.2 Plant Derivatives
  4. 4.1.3 Others
  5. 4.2 Global Natural and Bio-Based Antimicrobials Sales Volume by Type
  6. 4.2.1 Global Natural and Bio-Based Antimicrobials Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Natural and Bio-Based Antimicrobials Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Natural and Bio-Based Antimicrobials Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Natural and Bio-Based Antimicrobials Sales Value by Type
  10. 4.3.1 Global Natural and Bio-Based Antimicrobials Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Natural and Bio-Based Antimicrobials Sales Value by Type (2021-2032)
  12. 4.3.3 Global Natural and Bio-Based Antimicrobials Sales Value Share by Type (2021-2032)
5 Natural and Bio-Based Antimicrobials Market by Application
  1. 5.1 Natural and Bio-Based Antimicrobials Application Introduction
  2. 5.1.1 Cosmetic
  3. 5.1.2 Food
  4. 5.1.3 Medicine
  5. 5.1.4 Others
  6. 5.2 Global Natural and Bio-Based Antimicrobials Sales Volume by Application
  7. 5.2.1 Global Natural and Bio-Based Antimicrobials Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Natural and Bio-Based Antimicrobials Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Natural and Bio-Based Antimicrobials Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Natural and Bio-Based Antimicrobials Sales Value by Application
  11. 5.3.1 Global Natural and Bio-Based Antimicrobials Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Natural and Bio-Based Antimicrobials Sales Value by Application (2021-2032)
  13. 5.3.3 Global Natural and Bio-Based Antimicrobials Sales Value Share by Application (2021-2032)
6 Natural and Bio-Based Antimicrobials Regional Sales and Value Analysis
  1. 6.1 Global Natural and Bio-Based Antimicrobials Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Natural and Bio-Based Antimicrobials Sales by Region (2021-2032)
  3. 6.2.1 Global Natural and Bio-Based Antimicrobials Sales by Region: 2021-2026
  4. 6.2.2 Global Natural and Bio-Based Antimicrobials Sales by Region (2027-2032)
  5. 6.3 Global Natural and Bio-Based Antimicrobials Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Natural and Bio-Based Antimicrobials Sales Value by Region (2021-2032)
  7. 6.4.1 Global Natural and Bio-Based Antimicrobials Sales Value by Region: 2021-2026
  8. 6.4.2 Global Natural and Bio-Based Antimicrobials Sales Value by Region (2027-2032)
  9. 6.5 Global Natural and Bio-Based Antimicrobials Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Natural and Bio-Based Antimicrobials Sales Value (2021-2032)
  12. 6.6.2 North America Natural and Bio-Based Antimicrobials Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Natural and Bio-Based Antimicrobials Sales Value (2021-2032)
  15. 6.7.2 Europe Natural and Bio-Based Antimicrobials Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Natural and Bio-Based Antimicrobials Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Natural and Bio-Based Antimicrobials Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Natural and Bio-Based Antimicrobials Sales Value (2021-2032)
  21. 6.9.2 South America Natural and Bio-Based Antimicrobials Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Natural and Bio-Based Antimicrobials Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Natural and Bio-Based Antimicrobials Sales Value Share by Country, 2025 VS 2032
7 Natural and Bio-Based Antimicrobials Country-level Sales and Value Analysis
  1. 7.1 Global Natural and Bio-Based Antimicrobials Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Natural and Bio-Based Antimicrobials Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Natural and Bio-Based Antimicrobials Sales by Country (2021-2032)
  4. 7.3.1 Global Natural and Bio-Based Antimicrobials Sales by Country (2021-2026)
  5. 7.3.2 Global Natural and Bio-Based Antimicrobials Sales by Country (2027-2032)
  6. 7.4 Global Natural and Bio-Based Antimicrobials Sales Value by Country (2021-2032)
  7. 7.4.1 Global Natural and Bio-Based Antimicrobials Sales Value by Country (2021-2026)
  8. 7.4.2 Global Natural and Bio-Based Antimicrobials Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Natural and Bio-Based Antimicrobials Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Natural and Bio-Based Antimicrobials Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Natural and Bio-Based Antimicrobials Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Active Micro Technologies
  2. 8.1.1 Active Micro Technologies Company Information
  3. 8.1.2 Active Micro Technologies Business Overview
  4. 8.1.3 Active Micro Technologies Natural and Bio-Based Antimicrobials Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Active Micro Technologies Natural and Bio-Based Antimicrobials Product Portfolio
  6. 8.1.5 Active Micro Technologies Recent Developments
  7. 8.2 Akema Fine Chemicals
  8. 8.2.1 Akema Fine Chemicals Company Information
  9. 8.2.2 Akema Fine Chemicals Business Overview
  10. 8.2.3 Akema Fine Chemicals Natural and Bio-Based Antimicrobials Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Akema Fine Chemicals Natural and Bio-Based Antimicrobials Product Portfolio
  12. 8.2.5 Akema Fine Chemicals Recent Developments
  13. 8.3 Ashland
  14. 8.3.1 Ashland Company Information
  15. 8.3.2 Ashland Business Overview
  16. 8.3.3 Ashland Natural and Bio-Based Antimicrobials Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Ashland Natural and Bio-Based Antimicrobials Product Portfolio
  18. 8.3.5 Ashland Recent Developments
  19. 8.4 Chemipol
  20. 8.4.1 Chemipol Company Information
  21. 8.4.2 Chemipol Business Overview
  22. 8.4.3 Chemipol Natural and Bio-Based Antimicrobials Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Chemipol Natural and Bio-Based Antimicrobials Product Portfolio
  24. 8.4.5 Chemipol Recent Developments
  25. 8.5 DuPont Nutrition & Biosciences
  26. 8.5.1 DuPont Nutrition & Biosciences Company Information
  27. 8.5.2 DuPont Nutrition & Biosciences Business Overview
  28. 8.5.3 DuPont Nutrition & Biosciences Natural and Bio-Based Antimicrobials Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 DuPont Nutrition & Biosciences Natural and Bio-Based Antimicrobials Product Portfolio
  30. 8.5.5 DuPont Nutrition & Biosciences Recent Developments
  31. 8.6 Evident Ingredients
  32. 8.6.1 Evident Ingredients Company Information
  33. 8.6.2 Evident Ingredients Business Overview
  34. 8.6.3 Evident Ingredients Natural and Bio-Based Antimicrobials Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Evident Ingredients Natural and Bio-Based Antimicrobials Product Portfolio
  36. 8.6.5 Evident Ingredients Recent Developments
  37. 8.7 Evonik
  38. 8.7.1 Evonik Company Information
  39. 8.7.2 Evonik Business Overview
  40. 8.7.3 Evonik Natural and Bio-Based Antimicrobials Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Evonik Natural and Bio-Based Antimicrobials Product Portfolio
  42. 8.7.5 Evonik Recent Developments
  43. 8.8 Minasolve
  44. 8.8.1 Minasolve Company Information
  45. 8.8.2 Minasolve Business Overview
  46. 8.8.3 Minasolve Natural and Bio-Based Antimicrobials Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Minasolve Natural and Bio-Based Antimicrobials Product Portfolio
  48. 8.8.5 Minasolve Recent Developments
  49. 8.9 Sabinsa
  50. 8.9.1 Sabinsa Company Information
  51. 8.9.2 Sabinsa Business Overview
  52. 8.9.3 Sabinsa Natural and Bio-Based Antimicrobials Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Sabinsa Natural and Bio-Based Antimicrobials Product Portfolio
  54. 8.9.5 Sabinsa Recent Developments
  55. 8.10 SEPPIC
  56. 8.10.1 SEPPIC Company Information
  57. 8.10.2 SEPPIC Business Overview
  58. 8.10.3 SEPPIC Natural and Bio-Based Antimicrobials Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 SEPPIC Natural and Bio-Based Antimicrobials Product Portfolio
  60. 8.10.5 SEPPIC Recent Developments
  61. 8.11 Troy Corporation
  62. 8.11.1 Troy Corporation Company Information
  63. 8.11.2 Troy Corporation Business Overview
  64. 8.11.3 Troy Corporation Natural and Bio-Based Antimicrobials Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Troy Corporation Natural and Bio-Based Antimicrobials Product Portfolio
  66. 8.11.5 Troy Corporation Recent Developments
  67. 8.12 Vedeqsa
  68. 8.12.1 Vedeqsa Company Information
  69. 8.12.2 Vedeqsa Business Overview
  70. 8.12.3 Vedeqsa Natural and Bio-Based Antimicrobials Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Vedeqsa Natural and Bio-Based Antimicrobials Product Portfolio
  72. 8.12.5 Vedeqsa Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Natural and Bio-Based Antimicrobials Value Chain Analysis
  2. 9.1.1 Natural and Bio-Based Antimicrobials Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Natural and Bio-Based Antimicrobials Sales Mode & Process
  6. 9.2 Natural and Bio-Based Antimicrobials Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Natural and Bio-Based Antimicrobials Distributors
  9. 9.2.3 Natural and Bio-Based Antimicrobials Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst